Equillium (EQ) Total Liabilities (2017 - 2026)
Equillium (EQ) reported Total Liabilities of $3.6 million for Q1 2026, down 41.54% year-over-year from $6.2 million in Q1 2025, and up 9.3% quarter-over-quarter from $3.3 million in Q4 2025.
Equillium (EQ) Total Liabilities (2017 - 2026) Analysis & Trends
Equillium (EQ) has 10 years of Total Liabilities data on file, last reported at $3.6 million in Q1 2026.
- Total Liabilities for Q1 2026 came in at $3.6 million, down 41.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 million (down 41.54% YoY), and the FY2025 annual result was $3.3 million, down 49.72% from the prior year.
- Total Liabilities improved to $3.6 million in Q1 2026 per EQ's latest filing, from $3.3 million in the prior quarter.
- Over five years, Total Liabilities peaked at $46.5 million in Q4 2022 and troughed at $3.3 million in Q4 2025.
- A 5-year average of $19.3 million and a median of $20.5 million in 2022 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities surged 145.92% in 2022, then plunged 76.6% in 2024.
- A 5-year view of Total Liabilities shows it stood at $46.5 million in 2022, then tumbled by 39.85% to $28.0 million in 2023, then sank by 76.6% to $6.5 million in 2024, then plunged by 49.72% to $3.3 million in 2025, then grew by 9.3% to $3.6 million in 2026.
- Business Quant data shows EQ's Total Liabilities at $3.6 million in Q1 2026, $3.3 million in Q4 2025, and $3.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - | 3.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.60 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Jun 30, 2025 | 7.34 Mn |
| Mar 31, 2025 | 6.15 Mn |
| Dec 31, 2024 | 6.54 Mn |
| Sep 30, 2024 | 11.28 Mn |
| Jun 30, 2024 | 20.43 Mn |
| Mar 31, 2024 | 22.50 Mn |
| Dec 31, 2023 | 27.96 Mn |
| Sep 30, 2023 | 31.12 Mn |
| Jun 30, 2023 | 31.78 Mn |
| Mar 31, 2023 | 42.52 Mn |
| Dec 31, 2022 | 46.48 Mn |
| Sep 30, 2022 | 20.47 Mn |
| Jun 30, 2022 | 22.21 Mn |
| Mar 31, 2022 | 21.61 Mn |
| Dec 31, 2021 | 18.90 Mn |
| Sep 30, 2021 | 16.67 Mn |
| Jun 30, 2021 | 15.06 Mn |